HHS Articles, Harte-Hanks, Inc. - From 01/05/24

U.S. Rep Steve Cohen (D-TN) has fired a shot across the bow of the Drug Enforcement Administration (DEA), demanding swift action on the ongoing rev...

The Drug Enforcement Administration (DEA) told House lawmakers that the agency is “now conducting its review” of marijuana as a Schedul...

The Health and Human Services Department (HHS) released more details regarding its recommendation to the DEA to reclassify cannabis ...

A significant insider buy by Bradley Radoff, Board Member at Harte-Hanks (NASDAQ:HHS), was executed on December 5, and reported in the recent SEC f...

Over the past several years, the US cannabis industry has experienced many important milestones. Among the important ones are the 24 ...

What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future g...

The most overbought stocks in the communication services sector presents an opportunity to go short on these overvalued companies. The RSI is a mom...

Two political coalitions, the left-leaning Marijuana Justice Coalition and the conservative Cannabis Freedom Alliance have united to urge President...

A coalition of 31 bipartisan House members sent a letter to DEA administrator Anne Milgram, urging the agency to consider congressional and state m...

The Department of Health and Human Services disclosed a heavily redacted letter sent to the DEA concerning its recommendations for marijuana resche...